- Home
- MKDW vs QNCX Comparison
MKDW vs QNCX Comparison
Compare MKDW & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- QNCX
- Stock Information
- Founded
- MKDW 2006
- QNCX 2012
- Country
- MKDW Taiwan
- QNCX United States
- Employees
- MKDW N/A
- QNCX N/A
- Industry
- MKDW
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKDW
- QNCX Health Care
- Exchange
- MKDW NYSE
- QNCX Nasdaq
- Market Cap
- MKDW 40.2M
- QNCX 43.2M
- IPO Year
- MKDW N/A
- QNCX 2019
- Fundamental
- Price
- MKDW $0.32
- QNCX $1.17
- Analyst Decision
- MKDW
- QNCX Strong Buy
- Analyst Count
- MKDW 0
- QNCX 5
- Target Price
- MKDW N/A
- QNCX $8.00
- AVG Volume (30 Days)
- MKDW 5.1M
- QNCX 244.0K
- Earning Date
- MKDW 07-21-2025
- QNCX 05-13-2025
- Dividend Yield
- MKDW N/A
- QNCX N/A
- EPS Growth
- MKDW N/A
- QNCX N/A
- EPS
- MKDW N/A
- QNCX N/A
- Revenue
- MKDW $3,670,722.00
- QNCX N/A
- Revenue This Year
- MKDW N/A
- QNCX N/A
- Revenue Next Year
- MKDW N/A
- QNCX N/A
- P/E Ratio
- MKDW N/A
- QNCX N/A
- Revenue Growth
- MKDW 16.40
- QNCX N/A
- 52 Week Low
- MKDW $0.17
- QNCX $0.51
- 52 Week High
- MKDW $5.52
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- QNCX 60.16
- Support Level
- MKDW N/A
- QNCX $1.01
- Resistance Level
- MKDW N/A
- QNCX $1.06
- Average True Range (ATR)
- MKDW 0.00
- QNCX 0.09
- MACD
- MKDW 0.00
- QNCX 0.02
- Stochastic Oscillator
- MKDW 0.00
- QNCX 89.28
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.